CureVac is back in the Covid-19 vaccine game, this time with ‘lessons learned’

CureVac NV, a German biopharmaceutical company with U.S. headquarters in Boston, is back in the Covid-19 vaccine game — about a year after it abandoned its first attempt. The CEO detailed the company's approach this time.

Restaurant Roundup: Ole Red opens new spot, Mexican eatery relocating to West End, Whiskey Live to stop in Nashville

Viewpoint: Children’s Institute CEO Kali Thorne Ladd on how the success of children requires the brilliance of business minds

Greensboro unit leads Syngenta in quarterly sales growth

Developer wins approval for affordable housing in Sweetwater

Business First opens nominations for inaugural health care awards

Fifth + Broadway cracks nation’s Top 5 real estate transactions list

Tennis star Rafael Nadal misses shot at South Florida tennis academy

Fidelity Investments vacates entire office building in Durham before lease is up

CureVac is back in the Covid-19 vaccine game, this time with ‘lessons learned’

Previous Art Oberto, showman behind beef jerky producer, dies at 95

Next Houston-based real estate firm Arrowstar sees growth from focusing on value-add apartments

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Greensboro builder plans luxury townhomes across from Friendly Center

Fifth Third gives $1M to benefit shooting victims

Small Plates: Tarrytown gets new eats, The Grove gets American bistro

Thrive’s Bada Bean Bada Booze opening its second location this week

Long Island industrial portfolio sells near JFK airport

Broncos team president pays $4M for Observatory Park home

MENU

FirstStar Group

More Stories

PNC planning ‘national digital expansion’ with an ‘ultra-thin branch network’